Shire PLC Sustainability Reports

A global biopharmaceutical company focused on developing and marketing medicines for rare diseases and highly specialized conditions.

Sector: Manufacturing

Country: Ireland

Exchange: London Stock Exchange

LEI: 54930005LQRLI2UXRQ59

FIGI: BBG001S638Q4

9 reports from 2003 to 2017

• Shire PLC 2017 Annual Responsibility Review
• Shire PLC 2016 Annual Responsibility Review
• Shire PLC 2015 Annual Responsibility Review
• Shire PLC 2014 Annual Responsibility Review
• Shire PLC 2010 Responsibility Highlights